‘The starting point in the Competition Appeal Tribunal (CAT) is that no order for costs should be made against an unsuccessful regulator acting purely in its regulatory capacity, the Court of Appeal has ruled.’
Litigation Futures, 26th May 2020
Source: www.litigationfutures.com
‘This was a claim by Akebia Therapeutics Inc.(“Akebia”) and Otsuka Pharmaceutical Co. Ltd. (“Otsuka”) to revoke 6 patents held by FibroGen Inc. (“FibroGen”). The reason why they sought the revocation of those patents is that they wished to market their own product vadadustat. FibroGen’s exclusive licensee, Astellas Pharma Inc (“Astellas”) brought quia timet infringement proceedings against Akebia, Otsuka and FibroGen. The proceedings came on before Lord Justice Arnold between 2 and 19 March 2020. His lordship delivered judgment on 20 April 2020.’
NIPC Law, 5th May 2020
Source: nipclaw.blogspot.com
‘The advertising watchdog has cracked down on three companies for implying they could provide immune-boosting IV drips that could prevent or treat coronavirus.’
The Guardian, 22nd April 2020
Source: www.theguardian.com
‘This was an appeal by Bayer Plc and Novartis Pharmaceuticals UK Limited against Mrs Justice Whipple’s judgment in Bayer Plc v NHS Darlington Clinical Commissioning Groups and others : [2019] PTSR 922, [2018] WLR(D) 589, [2018] EWHC 2465 (Admin) which I blogged in Bayer Plc v NHS Darlington CCG and Others 2 Oct 2018. In her judgment, Mrs Justice Whipple dismissed applications for judicial review by Bayer and Novartis of a decision by NHS Darlington and other Clinical Commissioning Groups in Northeast England that the NHS Trusts from which they commission services should use a drug called Avastin as the preferred treatment option for an eye disease generally referred to as wet age-related macular degeneration (“WAMD”).’
NIPC Law, 7th April 2020
Source: nipclaw.blogspot.com
‘An online dealer has been convicted of killing a woman who took toxic tablets sold to her as slimming pills.’
BBC News, 9th March 2020
Source: www.bbc.co.uk
‘Following an investigation, the CMA has found that 4 pharmaceutical companies broke competition law in relation to the supply of an antidepressant.’
gov,uk, 4th March 2020
Source: www.gov.uk
‘The family of a two-year-old boy with a rare medical condition is taking an NHS Trust to court for refusing to prescribe a cannabis-based treatment they believe is helping him.’
Each Other, 12th February 2020
Source: eachother.org.uk
‘Cannabis, good drug or bad? The topic of debate internationally for decades by governments, medical professionals, recreational users and more. A renewed debate about the laws prohibiting or permitting cannabis use and supply around the world has been fuelled by the legalisation of supply and use of cannabis for ‘recreational’ purposes. Yasin Patel and Amy Hazlewood consider amongst other things, the use of cannabis, the legal history, advantages and disadvantages of legalising it.’
Church Court Chambers, January 2020
Source: churchcourtchambers.co.uk
‘Letter from the Home Secretary asking the Advisory Council on the Misuse of Drugs to review the classification of GHB and GBL.’
Home Office, 6th January 2020
Source: www.gov.uk/home-office
‘Carlisle Court acquitted an MS patient today of cultivating cannabis, following the Crown Prosecution Service’s decision not to offer evidence in court today on a public interest basis.’
Garden Court Chambers, 6th January 2020
Source: www.gardencourtchambers.co.uk
‘A hospital which gave a leukaemia patient five times the amount of drugs that she needed has today (Monday 9 December) been fined £45,000.’
Crown Prosecution Service, 9th December 2019
Source: www.cps.gov.uk
‘Prescription guidelines should be changed after a man died from using two medicines together, a coroner warned.’
BBC News, 13th November 2019
Source: www.bbc.co.uk
‘A recent ruling shows that businesses require strong evidence from customer surveys or expert witnesses to demonstrate the link between a colour and their brand to prevent rivals using the same colour to market their products, an expert in intellectual property law has said.’
OUT-LAW.com, 25th October 2019
Source: www.pinsentmasons.com
‘NHS leaders have gone to war on homeopathy by attempting to have the practice blacklisted amid fears it is fuelling anti-vax propaganda. The chief executive and medical director of NHS England have written to the Professional Standards Authority (PSA), the statutory body that oversees healthcare regulation, urging it to strip accreditation from the Society of Homeopaths (SoH).’
Daily Telegraph, 28th October 2019
Source: www.telegraph.co.uk
‘A dentist has been banned from practising for a year after one of his patients bled to death only hours after he extracted ten of her teeth.’
Daily Telegraph, 22nd October 2019
Source: www.telegraph.co.uk
‘The high court is to be asked to decide whether the statutory regulation of homeopaths is safe, amid concerns that some of those on an accredited register are offering an anti-vaccine “cure” for children with autism.’
The Guardian, 3rd October 2019
Source: www.theguardian.com
‘Cannabis-based drugs controversially legalised by the government have been blocked by NHS watchdogs because there is insufficient evidence they are safe.’
Daily Telegraph, 8th August 2019
Source: www.telegraph.co.uk
‘Anyone with more than 30,000 social media followers is now considered a celebrity and subject to advertising rules, a watchdog has ruled in the first case of its kind.’
Daily Telegraph, 2nd July 2019
Source: www.telegraph.co.uk
‘An anti-vaxxer was paid compensation by Cardiff University after being kicked off their course for their beliefs.’
Daily Telegraph, 1st July 2019
Source: www.telegraph.co.uk
© Inner Temple Library 2025